CLASS II ONGOING Device recall · Reported 22 Jun 2022 · FDA Enforcement Report

t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM recalled

Tandem Diabetes Care is recalling t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with. The recall was initiated on 10 Sep 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesDexcom G5 - All Serial Numbers; Basal-IQ Technology - Software Versions 6.3.01 and Earlier
Quantity recalled5,206

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1258-2022
FDA event ID
90113
Recalling firm
Tandem Diabetes Care, San Diego, CA
Classification
Class II
Status
Ongoing
Recall initiated
10 Sep 2020
FDA classified
10 Jun 2022
Reported
22 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

10 Sep 2020Recall initiated by company
10 Jun 2022Classified by FDA+638 days
22 Jun 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ Technology

Where it was distributed

International distribution in the country of Australia.

Questions about this recall

Why was it recalled?

Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.

Which lots are affected?

Dexcom G5 - All Serial Numbers; Basal-IQ Technology - Software Versions 6.3.01 and Earlier

Where was it sold?

International distribution in the country of Australia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tandem Diabetes Care

All 13

Other Insulin Pumps & Glucose Monitors recalls

All 468